[Thrombocyte antibodies. Clinical significance and a new method of membrane-bound antibodies]

Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up.

Leukemia & lymphoma·2016

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.

European journal of cancer (Oxford, England : 1990)·2007

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.

Medical oncology (Northwood, London, England)·2002

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.

Cancer chemotherapy and pharmacology·2001

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.

European journal of haematology·2000

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Blood·1999

[Overweight and lung diseases].

Ugeskrift for laeger·2026

[Sacral nerve modulation for urinary disorders].

Ugeskrift for laeger·2026

[Neurosyphilis in dementia cases].

Ugeskrift for laeger·2026

[Sternum fracture and troponinism after forced inspiration].

Ugeskrift for laeger·2026

[Newborn with neurofibromatosis type 1 and meningoencephalocele].

Ugeskrift for laeger·2026

[Automatic insulin pump systems in women with type 1 diabetes during and after pregnancy].

Ugeskrift for laeger·2026

Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).

Journal of Crohn's & colitis·2026

Long-term efficacy and safety for the complement factor B inhibitor iptacopan in IgA nephropathy.

Kidney international·2026

Correction: Macrophage polarization in acute myocardial infarction: multidimensional regulation and emerging therapeutic opportunitiesa.

Frontiers in immunology·2026

Comparative Effectiveness of Vedolizumab and Ustekinumab in Biologic-Experienced Ulcerative Colitis: A Real-World Multicenter Study from the Güntürk Group.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026

Inverse Vaccine Nanomimics: In situ Antigen-Specific Immune Tolerance Induction for Durable Cardiac Repair Post-Myocardial Infarction.

Research (Washington, D.C.)·2026

Biologic and small-molecule therapies for inflammatory bowel disease: mechanisms, comparative evidence and the emerging pipeline.

Frontiers in pharmacology·2026

Related Experiment Videos

[Thrombocyte antibodies. Clinical significance and a new method of membrane-bound antibodies]

Related Concept Videos

Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up.

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

[Overweight and lung diseases].

[Sacral nerve modulation for urinary disorders].

[Neurosyphilis in dementia cases].

[Sternum fracture and troponinism after forced inspiration].

[Newborn with neurofibromatosis type 1 and meningoencephalocele].

[Automatic insulin pump systems in women with type 1 diabetes during and after pregnancy].

Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).

Long-term efficacy and safety for the complement factor B inhibitor iptacopan in IgA nephropathy.

Correction: Macrophage polarization in acute myocardial infarction: multidimensional regulation and emerging therapeutic opportunitiesa.

Comparative Effectiveness of Vedolizumab and Ustekinumab in Biologic-Experienced Ulcerative Colitis: A Real-World Multicenter Study from the Güntürk Group.

Inverse Vaccine Nanomimics: In situ Antigen-Specific Immune Tolerance Induction for Durable Cardiac Repair Post-Myocardial Infarction.

Biologic and small-molecule therapies for inflammatory bowel disease: mechanisms, comparative evidence and the emerging pipeline.

Related Experiment Videos

[Thrombocyte antibodies. Clinical significance and a new method of membrane-bound antibodies]

Related Concept Videos

Related Articles